A photo of Rebecca Marsh.

Clinical Director, Primary Immune Deficiency Program

Co-Director, Diagnostic Immunology Laboratories

Associate Professor, UC Department of Pediatrics

513-636-3549

Board Certified

My Biography & Research

Academic Affiliation

Associate Professor, UC Department of Pediatrics

Divisions

Cancer and Blood Diseases, Immune Deficiencies and Histiocytosis, Bone Marrow Transplantation BMT, 22Q-VCFS, Hemophagocytic lymphohistiocytosisHLH, Bone Marrow Transplantation, Cancer and Blood Diseases

My Education

BS: University of Tennessee, Knoxville, TN, 1998.

MD: Rush Medical College, Chicago, IL, 2003.

Residency: Rush University Medical Center, Chicago, IL, 2006.

Fellowship: Cincinnati Children's Hospital Medical Center, Cincinnati, OH, 2008.

My Publications

Hematopoietic Cell Transplantation in Patients With Primary Immune Regulatory Disorders (PIRD): A Primary Immune Deficiency Treatment Consortium (PIDTC) Survey. Chan, AY; Leiding, JW; Liu, X; Logan, BR; Burroughs, LM; Allenspach, EJ; Skoda-Smith, S; Uzel, G; Notarangelo, LD; Slatter, M; et al. Frontiers in Immunology. 2020; 11.

CD38brightCD8+ T Cells Associated with the Development of Acute GVHD Are Activated, Proliferating, and Cytotoxic Trafficking Cells. Khandelwal, P; Chaturvedi, V; Owsley, E; Lane, A; Heyenbruch, D; Lutzko, CM; Leemhuis, T; Grimley, MS; Nelson, AS; Davies, SM; et al. Biology of Blood and Marrow Transplantation. 2020; 26:1-6.

The Value of Chromosome Analysis to Interrogate Variants in DNMT3B Causing Immunodeficiency, Centromeric Instability, and Facial Anomaly Syndrome Type I (ICF1). Kellner, ES; Rathbun, PA; Marshall, GS; Tolusso, LK; Smolarek, TA; Sun, M; Chandra, S; Bleesing, J; Marsh, RA. Journal of Clinical Immunology. 2019; 39:857-859.

Antibody deficiency testing for primary immunodeficiency: A practical review for the clinician. Marsh, RA; Orange, JS. Annals of Allergy, Asthma, and Immunology. 2019; 123:444-453.

Chronic Granulomatous Disease-Associated IBD Resolves and Does Not Adversely Impact Survival Following Allogeneic HCT. Marsh, RA; Leiding, JW; Logan, BR; Griffith, LM; Arnold, DE; Haddad, E; Falcone, EL; Yin, Z; Patel, K; Arbuckle, E; et al. Journal of Clinical Immunology. 2019; 39:653-667.

TNFR2 induced priming of the inflammasome leads to a RIPK1-dependent cell death in the absence of XIAP. Knop, J; Spilgies, LM; Rufli, S; Reinhart, R; Vasilikos, L; Yabal, M; Crowley, E; Jost, PJ; Marsh, RA; Wajant, H; et al. Cell Death and Disease. 2019; 10.

Current Flow Cytometric Assays for the Screening and Diagnosis of Primary HLH. Chiang, SC C; Bleesing, JJ; Marsh, RA. Frontiers in Immunology. 2019; 10.

Allogeneic hematopoietic stem cell transplant outcomes for patients with dominant negative IKZF1/IKAROS mutations. Kellner, ES; Krupski, C; Kuehn, HS; Rosenzweig, SD; Yoshida, N; Kojima, S; Boutboul, D; Latour, S; Barlogis, V; Galambrun, C; et al. Journal of Allergy and Clinical Immunology. 2019; 144:339-342.

Hemophagocytic Lymphohistiocytosis: Clinical Presentations and Diagnosis. Risma, KA; Marsh, RA. Journal of Allergy and Clinical Immunology-In Practice. 2019; 7:824-832.

Practice pattern changes and improvements in hematopoietic cell transplantation for primary immunodeficiencies. Marsh, RA; Hebert, KM; Keesler, D; Boelens, JJ; Dvorak, CC; Eckrich, MJ; Kapoor, N; Parikh, S; Eapen, M. Journal of Allergy and Clinical Immunology. 2018; 142:2004-2007.